Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
ConSep II™ Filter Module, a Game Changer in Fermentation and High Temperature Cross Flow Filtration Applications
The combination of the patented open channel design and the high temperature capabilities of the ConSep II™ filter module provide unique performance characteristics which customers describe as an "enabling technology" and "a game changer." - July 29, 2021 - SmartFlow Technologies
Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute (NHLBI)
Microvascular Therapeutics (MVT) has received funds from the from the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health for its program to treat cardiovascular disease, which kills more Americans than any other disease. As a leader in fluorocarbon... - July 19, 2021 - Microvascular Therapeutics
Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase I/II Universal Viral Vaccine Clinical Trial (ALLOPRIME) in Healthy Adults Over 65 Years Old
Mirror Biologics, Inc, (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ vaccines for cancer and infectious diseases where the active... - July 14, 2021 - Mirror Biologics, Inc.
Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase IIB Clinical Trial (STIMVAX) in Patients with Metastatic Colorectal Cancer
Mirror Biologics, Inc. (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ cancer vaccines in which the active ingredients are living... - July 09, 2021 - Mirror Biologics, Inc.
Drucker Diagnostics Aligns with Northern Optotronics Inc. (NOI) to Enhance and Expand Sales and Post Sales Service in Canada
Northern Optotronics Inc. (NOI) will begin to market and service Drucker Diagnostics’ world leading line of clinical centrifuges in the Canadian market. The alignment combines NOI’s deep understanding of the Canadian market with Drucker’s carefully designed medical centrifuges. - July 08, 2021 - NOI
Appoints CEO, Senior Executive, and Board of Directors: Peter M. Strumph, Chief Executive Officer; Brendan Classon PhD, Executive Vice President, Research and Development; Louis Demers, Vice President of Technical Operations; Matthew J. Hogan, member of the Board of Directors - July 06, 2021 - Parvus Therapeutics U.S., Inc.
Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. - July 03, 2021 - Defined Bioscience Inc.
Worldwide approval grants the Company exclusivity on a number of methods and manufacturing processes associated with its novel electrochemical biosensors. - July 01, 2021 - Pepex Biomedical, Inc.
Paras Biopharmaceuticals Finland Oy Named as One of the Top Pharma Outsourcing Companies in Europe 2021
Paras Biopharmaceuticals Highlights Company Innovations that Decode and Create Biologics Medicines for Unmet Medical Needs (Pharma Tech Outlook, USA) - June 22, 2021 - Paras Biopharmaceuticals Finland Oy
eMudhra, a global digital enabler and a premier provider of PKI and Cybersecurity solutions, announced that they have received SAFE Identity certification. - June 16, 2021 - eMudhra Inc.
Revolutionary AI-empowered interventional robotics firm, NDR Medical expands into Japan with Real Tech Global Fund. - June 10, 2021 - NDR Medical Technology
Lately, Creative Biolabs released its scholarship program for the year 2021. As an expert biotechnology CRO specialized in the field of antibody production and engineering, Creative Biolabs is always willing to support young and ambitious talents in the medical and science-related fields. The 2021... - June 10, 2021 - Creative Biolabs
vermicon Announces Participation at the 6th Microbiome Movement Drug Development Summit on June 29 – July 1, 2021 | Digital Event
Today vermicon AG, the microbiology specialists from Munich, announced that they will be participating in the Microbiome Movement Drug Development Summit 2021 as an Expertise Partner. The conference is being held in virtual form from June 29 till July 1. Dr. Jiri Snaidr, founder and CEO of vermicon... - June 10, 2021 - vermicon AG
Will Lead Organizational Focus on Addressing Racial & Social Equity within Life Sciences Industry. - June 07, 2021 - California Life Sciences
The “Association” and “Institute” will become “California Life Sciences” to better reflect the ecosystem it represents. - June 03, 2021 - California Life Sciences
2021 Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing and Changes Since 2020 - May 25, 2021 - Life Science Strategy Group, LLC
National Digital Health Mission Approves Plus91's MediXcel Digital Health Platform for Clinics, Labs, and Hospitals
Plus91's MediXcel Digital Health platform has been approved by the National Digital Health Mission (NDHM) for all 3 milestones. - May 22, 2021 - Plus91 Technologies Pvt Ltd
Orange Neurosciences is launching the world's largest survey of reading skills through its new app, ReadON Plus. The survey, which is free, will uncover information about reading fluency, grade-level reading levels, executive functioning, and cognitive skills. It will provide a clearer understanding of how people read and how they learn over time. This will provide information to policy-makers to improve learning and to provide the proper interventions. - May 18, 2021 - Orange Neurosciences
New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, is now providing state-of-the-art cancer care services at 96-10 Metropolitan Ave, Forest Hills, NY 11375. The newest location will provide cutting-edge cancer treatment, making it NYCBS’s... - May 17, 2021 - New York Cancer & Blood Specialists
BDA Partners is pleased to announce that Sanjay Singh has joined the firm as Managing Director and Head of BDA, India. He will lead the Mumbai office with BDA’s existing senior bankers in India. He will also co-head BDA’s Asian Healthcare team. Sanjay has over 20 years’... - May 17, 2021 - BDA Partners Ltd
Advanced Silicon Group Closes Seed Preferred Equity Offering and Adds Alan Watson and Sarah Kelly to Board
Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focused on developing novel biosensors, announced today the closing of a $1,020,000 seed preferred stock offering led by Cherrystone Angel Group with participation by MIT Alumni Angels of Northern California, Sidecar Angels and other private investors and the addition of two new Directors, Alan Watson, PhD, MBA and Sarah Kelly, PhD to its Board of Directors. - May 16, 2021 - Advanced Silicon Group
Cayman Chemical's new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This... - May 16, 2021 - Cayman Chemical Company
Mirror Biologics, Inc., a clinical stage biopharmaceutical company developing next generation immunotherapy treatments for cancer and infectious diseases, announces the appointment of Adi Raviv as interim Chief Executive Officer and member of the Board of Directors. "Adi brings a depth of... - May 12, 2021 - Mirror Biologics, Inc.
The Brooklyn Cancer Center has named noted leader and board-certified hematologist-oncologist Maxim Shulimovich, DO, as its new Chief of Hematology and Medical Oncology. His recruitment promises to lead the cancer center as a unified division to provide expert care and culturally sensitive services... - May 10, 2021 - The Brooklyn Cancer Center
Paras Biopharmaceuticals Finland Oy, a fast-growing, biopharmaceutical technology development company, based in Oulu, Finland, announced today that it is named as one of the top 30 admired companies to watch during 2021, by CIO Bulletin, USA. - April 28, 2021 - Paras Biopharmaceuticals Finland Oy
Linda Brings Deep Industry Experience and Human Resources Expertise to Meet West Coast Talent Demands - April 26, 2021 - Bench International
Cancer Expert Now's Chief Technology Officer, Dr. Rich Goldstein, recognized as a 2021 Digi-Tech Innovator Honoree. - April 23, 2021 - Cancer Expert Now, Inc.
Courage Therapeutics has been awarded an STTR grant by the National Insittute of Mental Health to design novel anorexia drugs. The grant is a follow-up to research by the Cone lab at the University of Michigan that recently published in Science Translational Research that MC3R is a potential target for therapeutic development in anorexia and obesity. The effort allows for an expeditious translation of basic science into eating disorders which have remained an area of significant unmet need. - April 23, 2021 - Courage Therapeutics
Immundiagnostik, Inc. Transitions to Eco-Friendly Kit Packaging to Further Support Sustainable Laboratory Initiatives
North American immunoassay supplier Immundiagnostik, Inc. has transitioned its ELISA and assay kit packaging to eco-friendly materials to further support sustainable laboratory initiatives. The new bio-based packaging made by Paper Foam® is 100% compostable and eco-friendly. In addition, the organization offers custom bulk packaging services for high throughput labs working to reduce their environmental impact. More information can be found at https://www.idkna.com. - April 21, 2021 - Immundiagnostik, Inc.
The global COVID-19 pandemic has demonstrated that neither current systems nor related technologies are capable of preventing or even successfully controlling the spread of zoonotic infectious agents. One of the prominent features of these infectious organisms is their ability to infect both people... - March 30, 2021 - GeneThera Inc.
Free COVID Care Delivers More than Expected, Offers Testing, Rapid Test Results and Other Options to Chicago Community
Free COVID Care delivers services other facilities opt not to. The services are designed to quickly and efficiently mitigate the spread of the Coronavirus. - March 29, 2021 - Free COVID Care
Courage Therapeutics Raises $1M for Treatment of Anorexia Nervosa and Other Related Eating Disorders
Courage Therapeutics raised $1M towards development of treatments for eating disorders including Anorexia Nervosa, ARFID, BED and genetic obesity. The company is led by Dan Housman a parent of children with eating disorders. The round was led by Michigan Biomedical Ventures. Funding will be used to test Courage’s proprietary compounds in animal models of eating disorders. The technology is based on the research on MC3R at the University of Michigan from co-founder Dr. Roger Cone’s lab. - March 24, 2021 - Courage Therapeutics
CyboSoft Releases pH Control System Design Guide to Help Customers Comply with EPA Rules and Achieve Quick ROI
CyboSoft's pH Control System Design Guide can help industrial plants meet wastewater discharge codes, save chemical reagents, and improve plant safety and productivity. - March 22, 2021 - CyboSoft
Best Health Care Website to be Named by Web Marketing Association in 25th Annual WebAward Competition
The Web Marketing Association will name the best healthcare websites of 2021 as part of their 25th annual international WebAward Competition for Web site development at www.webaward.org. The WebAwards sets benchmarks for 96 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites. - March 16, 2021 - Web Marketing Association
AbboMax introduces a panel of monoclonal and polyclonal anti-connexin antibodies. There are 21 different types of connexins which are known to exist in humans and 20 types in mice. Their abnormal expression and function are associated with human hereditary diseases. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. - March 15, 2021 - AbboMax, Inc.
Eurofins Viracor BioPharma Launches PanCancerIQ Comprehensive Genomic Profiling Service to Advance Precision Oncology Clinical Drug Development
Eurofins Viracor BioPharma Services, a global leader in specialty bioanalytical testing services, announces the launch of their new PanCancerIQ genomic profiling test; a next-generation sequencing (NGS) service that enables comprehensive genomic profiling of tumor samples. In addition to expanding... - March 11, 2021 - Eurofins Viracor BioPharma
The Best Medical Websites of 2021 will be named as part of the 25th annual WebAward Competition for Web site development at www.webaward.org. The WebAwards sets benchmarks fofr excellence for 96 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites, based on the seven criteria of a successful web site. The deadline for medical-related websites to enter to be judged is May 28, 2021. - March 11, 2021 - Web Marketing Association
New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, announces Ruth M. Morgan, DC, as Chief Research Officer. In this position, Ruth will oversee all research operations, providing leadership to ensure excellence in research performance and... - March 09, 2021 - New York Cancer & Blood Specialists
Jason Amada is a New York-based medical sales representative who started his career in the field of Finance. In 2019, he made the switch to medicine and considers it to be one of the best decisions of his life. His long-lost love for medicine was realized with his career transition. He has been... - March 04, 2021 - Jason Amada: Medical Sales
Ba Organics has released an innovative line of CBD nutraceuticals called Adaptoids. The wellness tablets are the first of it's kind to deliver accurate doses of hemp-derived cannabinoids and organic whole-fruits aimed at reducing stress and providing daily antioxidant support in one. - March 03, 2021 - Ba Organics LLC
STAT proteins (Signal transducers and activators of transcription) are cytoplasmic transcription factors that play an essential role in transmitting signals from the cellular membrane to the nucleus. Misregulation of STAT pathway frequently leads to tumorogenesis. AbboMax introduces a panel of monoclonal and polyclonal anti-STAT antibodies. - February 27, 2021 - AbboMax, Inc.
CloudLIMS’ COVID-19 LIMS solution has integrated with Folio's mobile app to enable receiving, storing, and sharing of COVID-19 test results securely and digitally. - February 18, 2021 - CloudLIMS
Paras Biopharmaceuticals Finland Oy Affordable Healthcare Efforts Viewed in Over 90 Countries: Biosimilar Technologies Get Attention
Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is a Finland-based microbial biologics company which focuses on the development of technologies for biosimilars and biologics in an efficient manner. The overall objective of Paras Biopharma is to enable economical production and future availability of affordable medicines for unmet medical needs. - February 17, 2021 - Paras Biopharmaceuticals Finland Oy
New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, has named board-certified hematopathologist Riem Badr, MD, FCAP, the chief of Pathology and Laboratory Services. https://nycancer.com/blog/2021/02/16/riem-badr-md-fcap-named-chief-pathology/ Dr. - February 16, 2021 - New York Cancer & Blood Specialists
Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. - February 11, 2021 - Pepex Biomedical, Inc.
5-ALA Fluorescence Technique Allows More Precise Tumor Resection - February 11, 2021 - Swedish Medical Center
New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, announces Richard Zuniga, MD, as the Chief of Research. https://nycancer.com/blog/2021/02/02/chief-of-research/ Dr. Zuniga is a board-certified hematologist and oncologist at NYCBS. Before... - February 03, 2021 - New York Cancer & Blood Specialists
Charles River CFO, Inc. (CRCFO), a provider of part-time and interim CFO and accounting services, today announced Kevin Sarney has joined the leadership team as the Life Sciences Practice Leader and CFO. With over 20 years of experience in public and private life sciences companies, Kevin will lead... - January 21, 2021 - Charles River CFO
AltuCell Therapeutics Announces Proof-of-Concept in Lead Programs in Type 1 Diabetes in Human Subjects; Phase 1 Pilot in Humans Has IND Approval & Trial to Begin Shortly
AltuCell Therapeutics, Inc., AltuCell announced today the achievement of approval of IND in Italy after pre-clinical proof-of-concept based on data from its two lead programs for type 1 diabetes testing of cadaver stem cell-derived islets in both human and non-human subjects. Their capsules have been implanted in people with diabetes for 5 year, demonstrating long-term safety, with no toxicity or tissue necrosis, and no rejection in any of the patients treated. - January 15, 2021 - AltuCell Therapeutics
AbboMax adds over a dozen new anti-cytokeratin monoclonal antibodies to its inventory. Cytokeratins are proteins found in epithelium. A variety of cytokeratins can be used for subtyping various forms of epithelial differentiation or for the detection of possible sites of origin of tumors. Primary tumors usually recapitulate the cytokeratin profiles of the cells from which they are derived. They are one of the most effective epithelial differentiation and tumor markers. - January 13, 2021 - AbboMax, Inc.